Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR1H2 | P55055 | 1/20 | 0.49 |
| ▸ | NR1H3 | Q13133 | 1/20 | 0.49 |
| ▸ | CA12 | O43570 | 3/20 | 0.46 |
| ▸ | CA1 | P00915 | 3/20 | 0.46 |
| ▸ | CA2 | P00918 | 3/20 | 0.46 |
| ▸ | CA7 | P43166 | 3/20 | 0.46 |
| ▸ | CA9 | Q16790 | 3/20 | 0.46 |
| ▸ | CA14 | Q9ULX7 | 3/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.45 |
| ▸ | MAPT | P10636 | 4/20 | 0.45 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.45 |
| ▸ | TSHR | P16473 | 2/20 | 0.45 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.45 |
| ▸ | USP2 | O75604 | 1/20 | 0.43 |
| ▸ | PKM | P14618 | 2/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.42 |
| ▸ | HPGD | P15428 | 2/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19680127 | 0.90 | NR1H2 (0.45) | NR1H2NR1H3CA12CA1CA2 | |
| SCHEMBL31643701 | 0.81 | CYP3A4 (0.63) | NR1H2NR1H3CA12CA1CA2 | |
| SCHEMBL19677653 | 0.78 | NR1H2 (0.54) | NR1H2NR1H3CA12CA1CA2 | |
| SCHEMBL19409973 | 0.77 | NR1H2 (0.72) | NR1H2NR1H3CA12CA1CA2 | |
| SCHEMBL27853304 | 0.77 | CA12 (0.54) | NR1H2NR1H3CA12CA1CA2 | |
| SCHEMBL19666785 | 0.74 | CA12 (0.42) | NR1H2NR1H3CA12CA1CA2 | |
| SCHEMBL11316813 | 0.73 | PTGES (0.55) | NR1H2NR1H3CYP3A4TDP1SMN1; SMN2 | |
| SCHEMBL19680128 | 0.72 | NR1H2 (0.51) | NR1H2NR1H3CA12CA1CA2 | |
| SCHEMBL9579726 | 0.71 | CA12 (0.59) | NR1H2NR1H3CA12CA1CA2 | |
| SCHEMBL6864419 | 0.71 | CA12 (0.63) | NR1H2NR1H3CA12CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-102351706-B | Method for synthesizing ethyldivaricatinate and application of ethyldivaricatinate | JIANGSU CHINA TOBACCO IND CO LTD | 2013-08-07 | — | — | CN | claimed |
| CN-102351706-A | Method for synthesizing ethyldivaricatinate and application of ethyldivaricatinate | JIANGSU CHINA TOBACCO IND CO LTD | 2012-02-15 | — | — | CN | claimed |
| US-20170349517-A1 | Crystalline Cannabidivarin | S&B PHARMA, INC., DBA NORAC PHARMA | 2017-12-07 | — | — | US | disclosed |
| US-20170349517-A1 | Crystalline Cannabidivarin | S&B PHARMA, INC., DBA NORAC PHARMA | 2017-12-07 | — | — | US | disclosed |
| CN-102351706-B | Method for synthesizing ethyldivaricatinate and application of ethyldivaricatinate | JIANGSU CHINA TOBACCO IND CO LTD | 2013-08-07 | — | — | CN | disclosed |
| CN-102351706-A | Method for synthesizing ethyldivaricatinate and application of ethyldivaricatinate | JIANGSU CHINA TOBACCO IND CO LTD | 2012-02-15 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170349517-A1 | Crystalline Cannabidivarin | CNR2, CNR1, NCSTN | NR1H2 59/4885NR1H3 43/4885CA12 621/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.